Real-time enrollment status for this severe asthma clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT05813288 |
| Recruiting Status | Terminated |
| Condition | Severe Asthma |
| Phase | Clinical Trial |
| Target Enrollment | 930 participants |
| Active Locations | 68 sites in the US |
| Sponsor | Areteia Therapeutics |
| Last Updated on CT.gov | December 15, 2025 (Dec 15, 2025) |
As of March 2, 2026: Clinical trial NCT05813288 is currently terminated participants. This clinical trial study for severe asthma is not currently accepting new participants at 68 locations across the United States. The study is sponsored by Areteia Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05813288 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 68 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05813288 was last updated Dec 15, 2025 (December 15, 2025). HelloStudys verifies this status automatically.